Access to Diagnostics and Treatment for People With Metastatic EGFR-Positive NSCLC: Lessons From Project PRIORITY

The TKI era has been practice changing; however, little is understood from the perspective of people living with EGFR-m NSCLC. This paper is the first to explore this and found it is possible to have people self-report complex health information about their lung cancer. In addition, although most participants were diagnosed after osimertinib became guideline-recommended treatment, disparities in treatment were identified.

Authors

Institutions

Publication Details

Journal
JTO Clinical and Research Reports
Published
2024-12-18
DOI
https://doi.org/10.1016/j.jtocrr.2024.100782
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Access to Diagnostics and Treatment for People With Metastatic EGFR-Positive NSCLC: Lessons From Project PRIORITY

Carly Johnson, Bellinda L. King‐Kallimanis, Alecia Clary, Jill Feldman et al.
JTO Clinical and Research Reports
Lung Cancer Treatments and Mutations
article

Access to Diagnostics and Treatment for People With Metastatic EGFR-Positive NSCLC: Lessons From Project PRIORITY

Carly Johnson, Bellinda L. King‐Kallimanis, Alecia Clary, Jill Feldman, Zofia Piotrowska, Teri Kennedy, I. Elkins, T. Chihuri, Upal Roy
article en

Abstract

The TKI era has been practice changing; however, little is understood from the perspective of people living with EGFR-m NSCLC. This paper is the first to explore this and found it is possible to have people self-report complex health information about their lung cancer. In addition, although most participants were diagnosed after osimertinib became guideline-recommended treatment, disparities in treatment were identified.

JTO Clinical and Research ReportsVol. 6(3)
Walgreens Boots Alliance (United States) (US), Massachusetts General Hospital (US), LUNGevity Foundation (US), Total Child Health (United States) (US)
LUNGevity Foundation
Good health and well-being
Openalex Percentile: Top 57%
Lung Cancer Treatments and Mutations
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Access to Diagnostics and Treatment for People With Metastatic EGFR-Positive NSCLC: Lessons From Project PRIORITY — Carly Johnson, Bellinda L. King‐Kallimanis, et al. · JTO Clinical and Research Reports (2024) | TGRS Research Map | TGRS